PMID: 8990174Jan 7, 1997Paper

Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice

Proceedings of the National Academy of Sciences of the United States of America
P SamamaR J Lefkowitz

Abstract

Transgenic overexpression (40- to 100-fold) of the wild-type human beta2-adrenergic receptor in the hearts of mice leads to a marked increase in cardiac contractility, which is apparently due to the low level of spontaneous (i.e., agonist-independent) activity inherent in the receptor. Here we report that transgenic mice expressing a mutated constitutively active form of the receptor (CAM) show no such phenotype, owing to its modest expression (3-fold above endogenous cardiac beta-adrenergic receptor levels). Surprisingly, treatment of the animals with a variety of beta-adrenergic receptor ligands leads to a 50-fold increase in CAM beta2-adrenergic receptor expression, by stabilizing the CAM beta2-adrenergic receptor protein. Receptor up-regulation leads in turn to marked increases in adenylate cyclase activity, atrial tension determined in vitro, and indices of cardiac contractility determined in vivo. These results illustrate a novel mechanism for regulating physiological responses, i.e., ligand-induced stabilization of a constitutively active but inherently unstable protein.

References

Sep 23, 1977·Biochemical and Biophysical Research Communications·G Glaubiger, R J Lefkowitz
Oct 1, 1992·Neuron·P R RobinsonD D Oprian
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·G PeiR J Lefkowitz
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·C A MilanoR J Lefkowitz
Aug 1, 1993·Trends in Pharmacological Sciences·R J LefkowitzT Costa

❮ Previous
Next ❯

Citations

Feb 12, 1998·Trends in Pharmacological Sciences·G Milligan, R A Bond
Aug 22, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·C M BullockQ Y Zhou
Feb 5, 2000·Neuroscience·M BjörklundP Riekkinen
Sep 10, 2002·Trends in Endocrinology and Metabolism : TEM·Charles ParnotEric Clauser
Apr 28, 2000·European Journal of Biochemistry·G Gimpl, F Fahrenholz
Jan 29, 1999·Annals of Surgery·J M Arbeit, R Hirose
Oct 21, 2009·The Journal of Pharmacology and Experimental Therapeutics·Jean-Philippe FortinAlan S Kopin
Jun 9, 2000·Annual Review of Physiology·W J KochH A Rockman
Jul 4, 2007·The Journal of Clinical Investigation·Sandrine BilletEric Clauser
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·S EngelhardtM J Lohse
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Yong Chen, Lee-Yuan Liu-Chen
May 5, 2000·Experimental Physiology·G GimplF Fahrenholz
Nov 24, 2004·Pharmacology & Therapeutics·Torsten SchönebergKatrin Sangkuhl
May 25, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Scott A GrandySusan E Howlett
Oct 24, 2007·Nature·Søren G F RasmussenBrian K Kobilka
Jun 20, 2003·Molecular Pharmacology·Vipa ChaipatikulPing-Yee Law
Nov 30, 2016·Journal of Ophthalmology·Paul HarasymowyczRadmila Day
Aug 8, 2018·The International Journal of Neuropsychopharmacology·Kelly A Berg, William P Clarke
Dec 1, 2001·The Journal of Biological Chemistry·Stéphanie Miserey-LenkeiEric Clauser
Jun 27, 1997·Biochemical and Biophysical Research Communications·S BétuingJ S Saulnier-Blache
Dec 16, 1998·Trends in Biochemical Sciences·R LeursH Timmerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.